TFFP - TFF Pharmaceuticals Inc. Net earnings per share (EPS TTM)

Symbol and logo of brand tffpharma.com (TFFP)

The pharmaceutical sector is facing the liquidation of TFF Pharmaceuticals (TFFP), whose assets are currently being sold off. The firm previously developed unique inhalation powder delivery methods and minimized costs through research outsourcing. The current value of the rolling annual EPS demonstrates the earnings per share trend, where -6.44 indicates the current level, determining the business's final margin of safety before closure.

TFFP (TFF Pharmaceuticals) Net earnings per one share for the last twelve months history from 07/04/2022 to 12/21/2024

TFF Pharmaceuticals Inc. (TFFP) - metric breakdowns and financial figures

- share price and expert price forecast:
Stock Quotes TFF Pharmaceuticals|TFFP - Analyst Forecast Prices
- market capitalization statistics:
Market Capitalization TFF Pharmaceuticals, Inc.|TFFP - Value Adjusted for Debt and Cash
- business book valuation details:
Book Value per Share TFF Pharmaceuticals|TFFP - Total Stockholders' Equity|Market Value to Book Value Ratio tffpharma.com|TFFP - Aggregate Asset Value
- debt obligations and liquidity statistics:
Total Debt to Equity Ratio TFF Pharmaceuticals|TFFP - Long-Term Loans to Capital Ratio|Short-Term Debt to Capital TFF Pharma|TFFP - Company Aggregate Indebtedness|Debts to Book Capitalization TFF Pharmaceuticals, Inc.|TFFP - Long-Term Liabilities|Company Current Liabilities TFF Pharmaceuticals|Quick Liquidity tffpharma.com
- net income and valuation multiples indicators:
TFFP - Profit After Tax|Projected Future Earnings TFF Pharmaceuticals|TFFP - Company Value to Net Income|Forward P/E Multiple TFF Pharmaceuticals, Inc.|TFFP - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization TFF Pharmaceuticals, Inc.|TFFP - Income before deduction of interest, taxes and amortization|Earnings per share for the last twelve months TFF Pharmaceuticals|TFFP - Net earnings per share for the last 12 months|Quarterly EPS earnings growth tffpharma.com|TFFP - Earnings growth in current year|Earnings growth forecast for next year TFF Pharmaceuticals
- revenue and sales proceeds data:
TFFP - Company Sales|Projected Sales Volume TFF Pharmaceuticals|TFFP - Price to Sales|Forward Price-to-Revenue Multiple TFF Pharmaceuticals, Inc.
Summary company analysis:TFF Pharmaceuticals (TFFP)
Flagship merchandise of TFF Pharmaceuticals Inc.

TFF Pharmaceuticals develops non-cyclical inhalation drug delivery technologies, the value of which is based on its patent portfolio. Net income per share (TTM) measures the final financial result distributed across the total volume of issuance for the year. This metric allows an investor to assess the real efficiency of business capitalization regardless of macroeconomic cycles. For this model, the indicator reflects the company's ability to transform partner budgets into shareholder value. Analyzing the dynamics of the rolling 12-month earnings per share helps identify hidden margin erosion.

Key competitors

HLN: Net earnings per share for the last 12 months|kenvue.com - Earnings per share for the last four quarters|VRNA: Net earnings per share (EPS TTM)|Jyong Biotech Limited - Earnings per share for the trailing year|LGND (Ligand Pharma) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Amneal Corp AMRX|Earnings per share for the last twelve months Perrigo Company plc (PRGO)|ALVO (alvotech.com) - Earnings per share for the trailing year|Liquidia - Net earnings per share for the last 12 months|Earnings per share for the last four quarters GLPG (Galapagos N.V.)|ANI Pharma - Net earnings per share (EPS TTM)|Earnings per one share for the last 12 months MNKD|AMPH: Net earnings per share (EPS TTM)|Earnings per one share for the last 12 months PCRX (pacira.com)|Net earnings per share for the last 12 months SPRY|TBPH: Earnings per share for the trailing year|Earnings per share for the last twelve months Aquestive Pharma (AQST)|SCPH: Earnings per one share for the last 12 months|Net earnings per share (EPS TTM) TECX (Tectonic Therapeutic)|Earnings per share for the trailing year TNXP|SXT China - Net earnings per share (EPS TTM)|EPRX - Net earnings per share (EPS TTM)|BioHarvest (BHST) - Earnings per share for the last twelve months|Invizyne - Earnings per share for the trailing year|Earnings per share for the last twelve months Oramed|Net earnings per share for the last 12 months Entera Bio Corp (ENTX)|Net earnings per share (EPS TTM) HYFT|Net earnings per share (EPS TTM) ABVC BioPharma Inc. (ABVC)|Net earnings per share (EPS TTM) CPIX (Cumberland Pharma)|QNTM - Net earnings per share for the last 12 months|FibroGen, Inc. - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months telomirpharma.com|RANI (ranitherapeutics.com) - Net earnings per share for the last 12 months|Synergy CHC (SNYR) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months RLYB|LEXX (Lexaria) - Earnings per share for the last four quarters|Net earnings per share (EPS TTM) PULM|Net earnings per share for the last four quarters ftzy.com.cn|Net earnings per share (EPS TTM) APM (Aptorum Group)|LYRA - Net earnings per share for the last 12 months|Impact BioMedical Inc - Net earnings per share (EPS TTM)|TNFA - Net earnings per share (EPS TTM)|cbdmd.com (YCBD) - Earnings per share for the last twelve months|PRFX (painreform.com) - Earnings per share for the last twelve months|Earnings per share for the last twelve months Altamira Therapeutics Ltd|Lipella Pharmaceuticals Inc (LIPO) - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months OPTN (Optinose)|Earnings per share for the last four quarters PIRS|Net earnings per share (EPS TTM) PROC (Procaps Group S.A.)|PTPI (petrospharma.com) - Earnings per one share for the last 12 months|Qilian International Holding - Net earnings per share (EPS TTM)|Earnings per one share for the last 12 months SLRN